Pharmicell Co., Ltd.

This study follows 100 people who had a heart attack and received a cell therapy called Hearticellgram-AMI. Researchers want to see if there are any long-term safety issues, such as death, new cancers, or immune system problems. Participants are simply observed over time to track…

This study checks the long-term safety of a stem cell treatment called Cellgram-ED for men with erectile dysfunction after prostate removal. It follows 32 participants from an earlier phase 2 trial, monitoring for serious side effects, new cancers, or prostate cancer recurrence. …